Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

<p>Trial schema</p>

Saved in:

書目詳細資料
主要作者:	Stephanie L. Wethington (16354020) (author)
其他作者:	Payal D. Shah (14942077) (author), Lainie Martin (16354023) (author), Janos L. Tanyi (15047976) (author), Nawar Latif (16354026) (author), Mark Morgan (16354029) (author), Drew A. Torigian (15047964) (author), Diego Rodriguez (16354032) (author), Simon A. Smith (16354035) (author), Emma Dean (16354038) (author), Susan M. Domchek (14944434) (author), Ronny Drapkin (14937867) (author), Ie-Ming Shih (14964062) (author), Eric J. Brown (16354041) (author), Wei-Ting Hwang (15045089) (author), Deborah K. Armstrong (15134754) (author), Stephanie Gaillard (14947156) (author), Robert Giuntoli (16354044) (author), Fiona Simpkins (15048000) (author)
出版:	2025
主題:	Cancer Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Drug Resistance Gynecological Cancers Ovarian cancer
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍